nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—CYP19A1—uterine cancer	0.529	1	CbGaD
Anastrozole—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0665	0.251	CbGbCtD
Anastrozole—CYP1A2—Progesterone—uterine cancer	0.0489	0.185	CbGbCtD
Anastrozole—CYP2C9—Progesterone—uterine cancer	0.0441	0.166	CbGbCtD
Anastrozole—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0387	0.146	CbGbCtD
Anastrozole—CYP3A4—Progesterone—uterine cancer	0.0256	0.0967	CbGbCtD
Anastrozole—CYP1A2—Etoposide—uterine cancer	0.0219	0.0826	CbGbCtD
Anastrozole—CYP19A1—corpus luteum—uterine cancer	0.0123	0.515	CbGeAlD
Anastrozole—CYP3A4—Etoposide—uterine cancer	0.0115	0.0433	CbGbCtD
Anastrozole—CYP3A4—Doxorubicin—uterine cancer	0.00782	0.0295	CbGbCtD
Anastrozole—CYP19A1—semen—uterine cancer	0.00575	0.241	CbGeAlD
Anastrozole—CYP19A1—endometrium—uterine cancer	0.00095	0.0399	CbGeAlD
Anastrozole—CYP19A1—uterus—uterine cancer	0.000876	0.0367	CbGeAlD
Anastrozole—CYP19A1—female reproductive system—uterine cancer	0.000787	0.033	CbGeAlD
Anastrozole—CYP19A1—female gonad—uterine cancer	0.000716	0.03	CbGeAlD
Anastrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.000689	0.0719	CbGpPWpGaD
Anastrozole—CYP1A2—renal system—uterine cancer	0.000659	0.0276	CbGeAlD
Anastrozole—CYP2C9—female reproductive system—uterine cancer	0.000501	0.021	CbGeAlD
Anastrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.000498	0.052	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.000498	0.052	CbGpPWpGaD
Anastrozole—CYP3A4—renal system—uterine cancer	0.000477	0.02	CbGeAlD
Anastrozole—CYP19A1—lymph node—uterine cancer	0.000461	0.0193	CbGeAlD
Anastrozole—CYP19A1—Endogenous sterols—CYP11A1—uterine cancer	0.000398	0.0415	CbGpPWpGaD
Anastrozole—CYP3A4—female reproductive system—uterine cancer	0.000382	0.016	CbGeAlD
Anastrozole—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000302	0.0315	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.000298	0.0311	CbGpPWpGaD
Anastrozole—CYP19A1—Ovarian Infertility Genes—MLH1—uterine cancer	0.000297	0.031	CbGpPWpGaD
Anastrozole—CYP19A1—Ovarian Infertility Genes—PGR—uterine cancer	0.000281	0.0294	CbGpPWpGaD
Anastrozole—CYP19A1—Ovarian Infertility Genes—ESR2—uterine cancer	0.000248	0.0258	CbGpPWpGaD
Anastrozole—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000232	0.0243	CbGpPWpGaD
Anastrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000185	0.0193	CbGpPWpGaD
Anastrozole—CYP19A1—Ovarian Infertility Genes—SMAD3—uterine cancer	0.000184	0.0192	CbGpPWpGaD
Anastrozole—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000182	0.019	CbGpPWpGaD
Anastrozole—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000181	0.00105	CcSEcCtD
Anastrozole—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000181	0.00105	CcSEcCtD
Anastrozole—Pruritus—Progesterone—uterine cancer	0.000179	0.00104	CcSEcCtD
Anastrozole—Oedema—Dactinomycin—uterine cancer	0.000179	0.00104	CcSEcCtD
Anastrozole—Hypertonia—Epirubicin—uterine cancer	0.000178	0.00104	CcSEcCtD
Anastrozole—Infection—Dactinomycin—uterine cancer	0.000178	0.00103	CcSEcCtD
Anastrozole—Vaginal infection—Doxorubicin—uterine cancer	0.000178	0.00103	CcSEcCtD
Anastrozole—Neuropathy—Doxorubicin—uterine cancer	0.000177	0.00103	CcSEcCtD
Anastrozole—Diarrhoea—Progesterone—uterine cancer	0.000173	0.00101	CcSEcCtD
Anastrozole—Erythema multiforme—Etoposide—uterine cancer	0.000172	0.001	CcSEcCtD
Anastrozole—Thrombophlebitis—Epirubicin—uterine cancer	0.000171	0.00099	CcSEcCtD
Anastrozole—Anorexia—Dactinomycin—uterine cancer	0.000171	0.00099	CcSEcCtD
Anastrozole—Neoplasm—Doxorubicin—uterine cancer	0.00017	0.000988	CcSEcCtD
Anastrozole—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.00017	0.000986	CcSEcCtD
Anastrozole—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000169	0.000981	CcSEcCtD
Anastrozole—Dizziness—Progesterone—uterine cancer	0.000167	0.000972	CcSEcCtD
Anastrozole—Hypertonia—Doxorubicin—uterine cancer	0.000165	0.000958	CcSEcCtD
Anastrozole—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000165	0.000955	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000163	0.000946	CcSEcCtD
Anastrozole—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000162	0.000942	CcSEcCtD
Anastrozole—Alopecia—Etoposide—uterine cancer	0.000161	0.000935	CcSEcCtD
Anastrozole—Vomiting—Progesterone—uterine cancer	0.000161	0.000934	CcSEcCtD
Anastrozole—Rash—Progesterone—uterine cancer	0.00016	0.000927	CcSEcCtD
Anastrozole—Dermatitis—Progesterone—uterine cancer	0.000159	0.000926	CcSEcCtD
Anastrozole—Headache—Progesterone—uterine cancer	0.000159	0.000921	CcSEcCtD
Anastrozole—Hot flush—Epirubicin—uterine cancer	0.000158	0.000917	CcSEcCtD
Anastrozole—Thrombophlebitis—Doxorubicin—uterine cancer	0.000158	0.000916	CcSEcCtD
Anastrozole—Increased appetite—Epirubicin—uterine cancer	0.000157	0.000913	CcSEcCtD
Anastrozole—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000157	0.000912	CcSEcCtD
Anastrozole—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000157	0.000911	CcSEcCtD
Anastrozole—Menopausal symptoms—Epirubicin—uterine cancer	0.000157	0.000909	CcSEcCtD
Anastrozole—Decreased appetite—Dactinomycin—uterine cancer	0.000156	0.000903	CcSEcCtD
Anastrozole—Dysgeusia—Etoposide—uterine cancer	0.000155	0.000902	CcSEcCtD
Anastrozole—Dermatitis bullous—Epirubicin—uterine cancer	0.000155	0.000897	CcSEcCtD
Anastrozole—Fatigue—Dactinomycin—uterine cancer	0.000154	0.000895	CcSEcCtD
Anastrozole—Back pain—Etoposide—uterine cancer	0.000153	0.000891	CcSEcCtD
Anastrozole—Pain—Dactinomycin—uterine cancer	0.000153	0.000888	CcSEcCtD
Anastrozole—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000153	0.000886	CcSEcCtD
Anastrozole—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000152	0.000881	CcSEcCtD
Anastrozole—Cerebrovascular accident—Epirubicin—uterine cancer	0.000151	0.000875	CcSEcCtD
Anastrozole—Lethargy—Epirubicin—uterine cancer	0.000151	0.000875	CcSEcCtD
Anastrozole—Nausea—Progesterone—uterine cancer	0.00015	0.000873	CcSEcCtD
Anastrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00015	0.0156	CbGpPWpGaD
Anastrozole—Osteoarthritis—Epirubicin—uterine cancer	0.000148	0.000857	CcSEcCtD
Anastrozole—Feeling abnormal—Dactinomycin—uterine cancer	0.000147	0.000856	CcSEcCtD
Anastrozole—Ill-defined disorder—Etoposide—uterine cancer	0.000147	0.000855	CcSEcCtD
Anastrozole—Anaemia—Etoposide—uterine cancer	0.000147	0.000851	CcSEcCtD
Anastrozole—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000146	0.000849	CcSEcCtD
Anastrozole—Hot flush—Doxorubicin—uterine cancer	0.000146	0.000848	CcSEcCtD
Anastrozole—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000146	0.000847	CcSEcCtD
Anastrozole—Increased appetite—Doxorubicin—uterine cancer	0.000145	0.000844	CcSEcCtD
Anastrozole—Menopausal symptoms—Doxorubicin—uterine cancer	0.000145	0.000841	CcSEcCtD
Anastrozole—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000145	0.00084	CcSEcCtD
Anastrozole—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000144	0.000839	CcSEcCtD
Anastrozole—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000144	0.000834	CcSEcCtD
Anastrozole—Malaise—Etoposide—uterine cancer	0.000143	0.000831	CcSEcCtD
Anastrozole—Dermatitis bullous—Doxorubicin—uterine cancer	0.000143	0.00083	CcSEcCtD
Anastrozole—Leukopenia—Etoposide—uterine cancer	0.000142	0.000824	CcSEcCtD
Anastrozole—Abdominal pain—Dactinomycin—uterine cancer	0.000141	0.000821	CcSEcCtD
Anastrozole—Body temperature increased—Dactinomycin—uterine cancer	0.000141	0.000821	CcSEcCtD
Anastrozole—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000141	0.00082	CcSEcCtD
Anastrozole—CYP19A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000141	0.0147	CbGpPWpGaD
Anastrozole—Mood swings—Epirubicin—uterine cancer	0.00014	0.000812	CcSEcCtD
Anastrozole—Lethargy—Doxorubicin—uterine cancer	0.000139	0.00081	CcSEcCtD
Anastrozole—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000139	0.00081	CcSEcCtD
Anastrozole—Cough—Etoposide—uterine cancer	0.000138	0.000804	CcSEcCtD
Anastrozole—Hypertension—Etoposide—uterine cancer	0.000137	0.000795	CcSEcCtD
Anastrozole—Osteoarthritis—Doxorubicin—uterine cancer	0.000137	0.000793	CcSEcCtD
Anastrozole—Liver function test abnormal—Epirubicin—uterine cancer	0.000136	0.000792	CcSEcCtD
Anastrozole—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000136	0.000791	CcSEcCtD
Anastrozole—Chest pain—Etoposide—uterine cancer	0.000135	0.000784	CcSEcCtD
Anastrozole—Discomfort—Etoposide—uterine cancer	0.000133	0.000775	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000133	0.000772	CcSEcCtD
Anastrozole—Hypersensitivity—Dactinomycin—uterine cancer	0.000132	0.000765	CcSEcCtD
Anastrozole—CYP19A1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000131	0.0137	CbGpPWpGaD
Anastrozole—Confusional state—Etoposide—uterine cancer	0.000131	0.000758	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.00013	0.000756	CcSEcCtD
Anastrozole—Anaphylactic shock—Etoposide—uterine cancer	0.000129	0.000752	CcSEcCtD
Anastrozole—Mood swings—Doxorubicin—uterine cancer	0.000129	0.000752	CcSEcCtD
Anastrozole—Infection—Etoposide—uterine cancer	0.000129	0.000747	CcSEcCtD
Anastrozole—Asthenia—Dactinomycin—uterine cancer	0.000128	0.000745	CcSEcCtD
Anastrozole—Dysphagia—Epirubicin—uterine cancer	0.000128	0.000741	CcSEcCtD
Anastrozole—Influenza—Epirubicin—uterine cancer	0.000128	0.000741	CcSEcCtD
Anastrozole—Liver function test abnormal—Doxorubicin—uterine cancer	0.000126	0.000732	CcSEcCtD
Anastrozole—Hyperhidrosis—Etoposide—uterine cancer	0.000125	0.000727	CcSEcCtD
Anastrozole—Angina pectoris—Epirubicin—uterine cancer	0.000124	0.000722	CcSEcCtD
Anastrozole—Anorexia—Etoposide—uterine cancer	0.000123	0.000717	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000123	0.000714	CcSEcCtD
Anastrozole—Bronchitis—Epirubicin—uterine cancer	0.000123	0.000713	CcSEcCtD
Anastrozole—Diarrhoea—Dactinomycin—uterine cancer	0.000122	0.000711	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000121	0.0007	CcSEcCtD
Anastrozole—Dysphagia—Doxorubicin—uterine cancer	0.000118	0.000686	CcSEcCtD
Anastrozole—Influenza—Doxorubicin—uterine cancer	0.000118	0.000686	CcSEcCtD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	0.000117	0.0122	CbGpPWpGaD
Anastrozole—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine cancer	0.000117	0.0122	CbGpPWpGaD
Anastrozole—Paraesthesia—Etoposide—uterine cancer	0.000116	0.000675	CcSEcCtD
Anastrozole—Weight increased—Epirubicin—uterine cancer	0.000116	0.000674	CcSEcCtD
Anastrozole—Weight decreased—Epirubicin—uterine cancer	0.000115	0.00067	CcSEcCtD
Anastrozole—Dyspnoea—Etoposide—uterine cancer	0.000115	0.00067	CcSEcCtD
Anastrozole—Somnolence—Etoposide—uterine cancer	0.000115	0.000668	CcSEcCtD
Anastrozole—Angina pectoris—Doxorubicin—uterine cancer	0.000115	0.000668	CcSEcCtD
Anastrozole—Vomiting—Dactinomycin—uterine cancer	0.000114	0.00066	CcSEcCtD
Anastrozole—Bronchitis—Doxorubicin—uterine cancer	0.000114	0.000659	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000113	0.000655	CcSEcCtD
Anastrozole—Rash—Dactinomycin—uterine cancer	0.000113	0.000655	CcSEcCtD
Anastrozole—Decreased appetite—Etoposide—uterine cancer	0.000113	0.000653	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Etoposide—uterine cancer	0.000112	0.000649	CcSEcCtD
Anastrozole—Fatigue—Etoposide—uterine cancer	0.000112	0.000648	CcSEcCtD
Anastrozole—Neuropathy peripheral—Epirubicin—uterine cancer	0.000112	0.000648	CcSEcCtD
Anastrozole—Jaundice—Epirubicin—uterine cancer	0.000111	0.000644	CcSEcCtD
Anastrozole—Constipation—Etoposide—uterine cancer	0.000111	0.000643	CcSEcCtD
Anastrozole—Pain—Etoposide—uterine cancer	0.000111	0.000643	CcSEcCtD
Anastrozole—Urinary tract infection—Epirubicin—uterine cancer	0.000111	0.000642	CcSEcCtD
Anastrozole—Sweating—Epirubicin—uterine cancer	0.000109	0.000633	CcSEcCtD
Anastrozole—Hepatobiliary disease—Epirubicin—uterine cancer	0.000108	0.000625	CcSEcCtD
Anastrozole—Weight increased—Doxorubicin—uterine cancer	0.000107	0.000624	CcSEcCtD
Anastrozole—Weight decreased—Doxorubicin—uterine cancer	0.000107	0.00062	CcSEcCtD
Anastrozole—Sinusitis—Epirubicin—uterine cancer	0.000107	0.00062	CcSEcCtD
Anastrozole—Feeling abnormal—Etoposide—uterine cancer	0.000107	0.000619	CcSEcCtD
Anastrozole—Nausea—Dactinomycin—uterine cancer	0.000106	0.000617	CcSEcCtD
Anastrozole—Gastrointestinal pain—Etoposide—uterine cancer	0.000106	0.000615	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000104	0.000606	CcSEcCtD
Anastrozole—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000103	0.000599	CcSEcCtD
Anastrozole—Urticaria—Etoposide—uterine cancer	0.000103	0.000597	CcSEcCtD
Anastrozole—Haemoglobin—Epirubicin—uterine cancer	0.000103	0.000596	CcSEcCtD
Anastrozole—Jaundice—Doxorubicin—uterine cancer	0.000103	0.000596	CcSEcCtD
Anastrozole—Rhinitis—Epirubicin—uterine cancer	0.000102	0.000595	CcSEcCtD
Anastrozole—Body temperature increased—Etoposide—uterine cancer	0.000102	0.000594	CcSEcCtD
Anastrozole—Abdominal pain—Etoposide—uterine cancer	0.000102	0.000594	CcSEcCtD
Anastrozole—Urinary tract infection—Doxorubicin—uterine cancer	0.000102	0.000594	CcSEcCtD
Anastrozole—Hepatitis—Epirubicin—uterine cancer	0.000102	0.000593	CcSEcCtD
Anastrozole—Haemorrhage—Epirubicin—uterine cancer	0.000102	0.000593	CcSEcCtD
Anastrozole—CYP19A1—Ovarian Infertility Genes—CDKN1B—uterine cancer	0.000102	0.0107	CbGpPWpGaD
Anastrozole—Pharyngitis—Epirubicin—uterine cancer	0.000101	0.000589	CcSEcCtD
Anastrozole—Sweating—Doxorubicin—uterine cancer	0.000101	0.000586	CcSEcCtD
Anastrozole—Oedema peripheral—Epirubicin—uterine cancer	0.000101	0.000584	CcSEcCtD
Anastrozole—Hepatobiliary disease—Doxorubicin—uterine cancer	9.96e-05	0.000578	CcSEcCtD
Anastrozole—Sinusitis—Doxorubicin—uterine cancer	9.88e-05	0.000574	CcSEcCtD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	9.76e-05	0.0102	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	9.76e-05	0.0102	CbGpPWpGaD
Anastrozole—Erythema multiforme—Epirubicin—uterine cancer	9.66e-05	0.000561	CcSEcCtD
Anastrozole—CYP19A1—Metapathway biotransformation—AKR1C1—uterine cancer	9.63e-05	0.0101	CbGpPWpGaD
Anastrozole—Hypersensitivity—Etoposide—uterine cancer	9.54e-05	0.000554	CcSEcCtD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	9.52e-05	0.00993	CbGpPWpGaD
Anastrozole—Haemoglobin—Doxorubicin—uterine cancer	9.5e-05	0.000552	CcSEcCtD
Anastrozole—Rhinitis—Doxorubicin—uterine cancer	9.48e-05	0.00055	CcSEcCtD
Anastrozole—Hepatitis—Doxorubicin—uterine cancer	9.45e-05	0.000549	CcSEcCtD
Anastrozole—Haemorrhage—Doxorubicin—uterine cancer	9.45e-05	0.000549	CcSEcCtD
Anastrozole—Pharyngitis—Doxorubicin—uterine cancer	9.38e-05	0.000545	CcSEcCtD
Anastrozole—Oedema peripheral—Doxorubicin—uterine cancer	9.31e-05	0.000541	CcSEcCtD
Anastrozole—Asthenia—Etoposide—uterine cancer	9.29e-05	0.000539	CcSEcCtD
Anastrozole—Pruritus—Etoposide—uterine cancer	9.16e-05	0.000532	CcSEcCtD
Anastrozole—Alopecia—Epirubicin—uterine cancer	9.03e-05	0.000524	CcSEcCtD
Anastrozole—CYP2C9—Arachidonic acid metabolism—AKR1C3—uterine cancer	8.94e-05	0.00933	CbGpPWpGaD
Anastrozole—Erythema multiforme—Doxorubicin—uterine cancer	8.94e-05	0.000519	CcSEcCtD
Anastrozole—Erythema—Epirubicin—uterine cancer	8.89e-05	0.000516	CcSEcCtD
Anastrozole—Diarrhoea—Etoposide—uterine cancer	8.86e-05	0.000514	CcSEcCtD
Anastrozole—Tension—Epirubicin—uterine cancer	8.73e-05	0.000507	CcSEcCtD
Anastrozole—Dysgeusia—Epirubicin—uterine cancer	8.71e-05	0.000506	CcSEcCtD
Anastrozole—Nervousness—Epirubicin—uterine cancer	8.64e-05	0.000501	CcSEcCtD
Anastrozole—Back pain—Epirubicin—uterine cancer	8.6e-05	0.000499	CcSEcCtD
Anastrozole—Dizziness—Etoposide—uterine cancer	8.56e-05	0.000497	CcSEcCtD
Anastrozole—CYP19A1—Metapathway biotransformation—GPX3—uterine cancer	8.46e-05	0.00882	CbGpPWpGaD
Anastrozole—Alopecia—Doxorubicin—uterine cancer	8.35e-05	0.000485	CcSEcCtD
Anastrozole—Ill-defined disorder—Epirubicin—uterine cancer	8.25e-05	0.000479	CcSEcCtD
Anastrozole—Vomiting—Etoposide—uterine cancer	8.23e-05	0.000478	CcSEcCtD
Anastrozole—Erythema—Doxorubicin—uterine cancer	8.23e-05	0.000478	CcSEcCtD
Anastrozole—Anaemia—Epirubicin—uterine cancer	8.22e-05	0.000477	CcSEcCtD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	8.18e-05	0.00854	CbGpPWpGaD
Anastrozole—Rash—Etoposide—uterine cancer	8.16e-05	0.000474	CcSEcCtD
Anastrozole—Dermatitis—Etoposide—uterine cancer	8.16e-05	0.000474	CcSEcCtD
Anastrozole—Headache—Etoposide—uterine cancer	8.11e-05	0.000471	CcSEcCtD
Anastrozole—Tension—Doxorubicin—uterine cancer	8.08e-05	0.000469	CcSEcCtD
Anastrozole—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	8.07e-05	0.00842	CbGpPWpGaD
Anastrozole—Dysgeusia—Doxorubicin—uterine cancer	8.06e-05	0.000468	CcSEcCtD
Anastrozole—Malaise—Epirubicin—uterine cancer	8.02e-05	0.000466	CcSEcCtD
Anastrozole—Nervousness—Doxorubicin—uterine cancer	7.99e-05	0.000464	CcSEcCtD
Anastrozole—CYP19A1—Biological oxidations—CYP11A1—uterine cancer	7.96e-05	0.00831	CbGpPWpGaD
Anastrozole—Leukopenia—Epirubicin—uterine cancer	7.96e-05	0.000462	CcSEcCtD
Anastrozole—Back pain—Doxorubicin—uterine cancer	7.96e-05	0.000462	CcSEcCtD
Anastrozole—CYP19A1—Metapathway biotransformation—CYP11A1—uterine cancer	7.85e-05	0.00819	CbGpPWpGaD
Anastrozole—Cough—Epirubicin—uterine cancer	7.76e-05	0.000451	CcSEcCtD
Anastrozole—Nausea—Etoposide—uterine cancer	7.69e-05	0.000447	CcSEcCtD
Anastrozole—Hypertension—Epirubicin—uterine cancer	7.68e-05	0.000446	CcSEcCtD
Anastrozole—CYP1A2—Arachidonic acid metabolism—AKR1C3—uterine cancer	7.64e-05	0.00797	CbGpPWpGaD
Anastrozole—Ill-defined disorder—Doxorubicin—uterine cancer	7.64e-05	0.000443	CcSEcCtD
Anastrozole—Anaemia—Doxorubicin—uterine cancer	7.61e-05	0.000442	CcSEcCtD
Anastrozole—Arthralgia—Epirubicin—uterine cancer	7.57e-05	0.00044	CcSEcCtD
Anastrozole—Myalgia—Epirubicin—uterine cancer	7.57e-05	0.00044	CcSEcCtD
Anastrozole—Chest pain—Epirubicin—uterine cancer	7.57e-05	0.00044	CcSEcCtD
Anastrozole—Anxiety—Epirubicin—uterine cancer	7.55e-05	0.000438	CcSEcCtD
Anastrozole—Discomfort—Epirubicin—uterine cancer	7.48e-05	0.000434	CcSEcCtD
Anastrozole—Malaise—Doxorubicin—uterine cancer	7.42e-05	0.000431	CcSEcCtD
Anastrozole—CYP19A1—Metapathway biotransformation—AKR1C3—uterine cancer	7.41e-05	0.00774	CbGpPWpGaD
Anastrozole—Dry mouth—Epirubicin—uterine cancer	7.41e-05	0.00043	CcSEcCtD
Anastrozole—Leukopenia—Doxorubicin—uterine cancer	7.37e-05	0.000428	CcSEcCtD
Anastrozole—Confusional state—Epirubicin—uterine cancer	7.32e-05	0.000425	CcSEcCtD
Anastrozole—Anaphylactic shock—Epirubicin—uterine cancer	7.26e-05	0.000421	CcSEcCtD
Anastrozole—Oedema—Epirubicin—uterine cancer	7.26e-05	0.000421	CcSEcCtD
Anastrozole—Infection—Epirubicin—uterine cancer	7.21e-05	0.000419	CcSEcCtD
Anastrozole—Cough—Doxorubicin—uterine cancer	7.18e-05	0.000417	CcSEcCtD
Anastrozole—Hypertension—Doxorubicin—uterine cancer	7.1e-05	0.000412	CcSEcCtD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	7.07e-05	0.00737	CbGpPWpGaD
Anastrozole—Hyperhidrosis—Epirubicin—uterine cancer	7.02e-05	0.000407	CcSEcCtD
Anastrozole—Arthralgia—Doxorubicin—uterine cancer	7.01e-05	0.000407	CcSEcCtD
Anastrozole—Myalgia—Doxorubicin—uterine cancer	7.01e-05	0.000407	CcSEcCtD
Anastrozole—Chest pain—Doxorubicin—uterine cancer	7.01e-05	0.000407	CcSEcCtD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	6.99e-05	0.00729	CbGpPWpGaD
Anastrozole—Anxiety—Doxorubicin—uterine cancer	6.98e-05	0.000405	CcSEcCtD
Anastrozole—Discomfort—Doxorubicin—uterine cancer	6.92e-05	0.000402	CcSEcCtD
Anastrozole—Anorexia—Epirubicin—uterine cancer	6.92e-05	0.000402	CcSEcCtD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	6.9e-05	0.0072	CbGpPWpGaD
Anastrozole—Dry mouth—Doxorubicin—uterine cancer	6.85e-05	0.000398	CcSEcCtD
Anastrozole—Confusional state—Doxorubicin—uterine cancer	6.77e-05	0.000393	CcSEcCtD
Anastrozole—Anaphylactic shock—Doxorubicin—uterine cancer	6.72e-05	0.00039	CcSEcCtD
Anastrozole—Oedema—Doxorubicin—uterine cancer	6.72e-05	0.00039	CcSEcCtD
Anastrozole—Infection—Doxorubicin—uterine cancer	6.67e-05	0.000387	CcSEcCtD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	6.63e-05	0.00692	CbGpPWpGaD
Anastrozole—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.61e-05	0.000384	CcSEcCtD
Anastrozole—Insomnia—Epirubicin—uterine cancer	6.56e-05	0.000381	CcSEcCtD
Anastrozole—Paraesthesia—Epirubicin—uterine cancer	6.52e-05	0.000378	CcSEcCtD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—STK11—uterine cancer	6.5e-05	0.00678	CbGpPWpGaD
Anastrozole—Hyperhidrosis—Doxorubicin—uterine cancer	6.49e-05	0.000377	CcSEcCtD
Anastrozole—Dyspnoea—Epirubicin—uterine cancer	6.47e-05	0.000376	CcSEcCtD
Anastrozole—Somnolence—Epirubicin—uterine cancer	6.45e-05	0.000375	CcSEcCtD
Anastrozole—Anorexia—Doxorubicin—uterine cancer	6.4e-05	0.000372	CcSEcCtD
Anastrozole—Dyspepsia—Epirubicin—uterine cancer	6.39e-05	0.000371	CcSEcCtD
Anastrozole—CYP1A2—Tryptophan metabolism—CYP19A1—uterine cancer	6.36e-05	0.00664	CbGpPWpGaD
Anastrozole—Decreased appetite—Epirubicin—uterine cancer	6.31e-05	0.000366	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Epirubicin—uterine cancer	6.27e-05	0.000364	CcSEcCtD
Anastrozole—Fatigue—Epirubicin—uterine cancer	6.26e-05	0.000363	CcSEcCtD
Anastrozole—CYP2C9—Metapathway biotransformation—AKR1B10—uterine cancer	6.25e-05	0.00652	CbGpPWpGaD
Anastrozole—CYP19A1—FSH signaling pathway—AKT1—uterine cancer	6.21e-05	0.00648	CbGpPWpGaD
Anastrozole—Constipation—Epirubicin—uterine cancer	6.21e-05	0.00036	CcSEcCtD
Anastrozole—Pain—Epirubicin—uterine cancer	6.21e-05	0.00036	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	6.12e-05	0.000355	CcSEcCtD
Anastrozole—Insomnia—Doxorubicin—uterine cancer	6.07e-05	0.000353	CcSEcCtD
Anastrozole—Paraesthesia—Doxorubicin—uterine cancer	6.03e-05	0.00035	CcSEcCtD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	6.02e-05	0.00628	CbGpPWpGaD
Anastrozole—Dyspnoea—Doxorubicin—uterine cancer	5.99e-05	0.000348	CcSEcCtD
Anastrozole—Feeling abnormal—Epirubicin—uterine cancer	5.98e-05	0.000347	CcSEcCtD
Anastrozole—Somnolence—Doxorubicin—uterine cancer	5.97e-05	0.000347	CcSEcCtD
Anastrozole—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	5.94e-05	0.0062	CbGpPWpGaD
Anastrozole—Gastrointestinal pain—Epirubicin—uterine cancer	5.94e-05	0.000345	CcSEcCtD
Anastrozole—Dyspepsia—Doxorubicin—uterine cancer	5.91e-05	0.000343	CcSEcCtD
Anastrozole—Decreased appetite—Doxorubicin—uterine cancer	5.84e-05	0.000339	CcSEcCtD
Anastrozole—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	5.81e-05	0.00606	CbGpPWpGaD
Anastrozole—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.8e-05	0.000337	CcSEcCtD
Anastrozole—Fatigue—Doxorubicin—uterine cancer	5.79e-05	0.000336	CcSEcCtD
Anastrozole—Urticaria—Epirubicin—uterine cancer	5.77e-05	0.000335	CcSEcCtD
Anastrozole—Pain—Doxorubicin—uterine cancer	5.74e-05	0.000333	CcSEcCtD
Anastrozole—Constipation—Doxorubicin—uterine cancer	5.74e-05	0.000333	CcSEcCtD
Anastrozole—Abdominal pain—Epirubicin—uterine cancer	5.74e-05	0.000333	CcSEcCtD
Anastrozole—Body temperature increased—Epirubicin—uterine cancer	5.74e-05	0.000333	CcSEcCtD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	5.67e-05	0.00591	CbGpPWpGaD
Anastrozole—Feeling abnormal—Doxorubicin—uterine cancer	5.53e-05	0.000321	CcSEcCtD
Anastrozole—Gastrointestinal pain—Doxorubicin—uterine cancer	5.49e-05	0.000319	CcSEcCtD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	5.4e-05	0.00563	CbGpPWpGaD
Anastrozole—Hypersensitivity—Epirubicin—uterine cancer	5.35e-05	0.00031	CcSEcCtD
Anastrozole—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	5.34e-05	0.00557	CbGpPWpGaD
Anastrozole—Urticaria—Doxorubicin—uterine cancer	5.34e-05	0.00031	CcSEcCtD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	5.32e-05	0.00556	CbGpPWpGaD
Anastrozole—Body temperature increased—Doxorubicin—uterine cancer	5.31e-05	0.000308	CcSEcCtD
Anastrozole—Abdominal pain—Doxorubicin—uterine cancer	5.31e-05	0.000308	CcSEcCtD
Anastrozole—Asthenia—Epirubicin—uterine cancer	5.21e-05	0.000302	CcSEcCtD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	5.14e-05	0.00537	CbGpPWpGaD
Anastrozole—Pruritus—Epirubicin—uterine cancer	5.14e-05	0.000298	CcSEcCtD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.11e-05	0.00533	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.11e-05	0.00533	CbGpPWpGaD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	5.08e-05	0.0053	CbGpPWpGaD
Anastrozole—Diarrhoea—Epirubicin—uterine cancer	4.97e-05	0.000288	CcSEcCtD
Anastrozole—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	4.96e-05	0.00518	CbGpPWpGaD
Anastrozole—Hypersensitivity—Doxorubicin—uterine cancer	4.95e-05	0.000287	CcSEcCtD
Anastrozole—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	4.91e-05	0.00512	CbGpPWpGaD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.88e-05	0.00509	CbGpPWpGaD
Anastrozole—Asthenia—Doxorubicin—uterine cancer	4.82e-05	0.00028	CcSEcCtD
Anastrozole—Dizziness—Epirubicin—uterine cancer	4.8e-05	0.000279	CcSEcCtD
Anastrozole—Pruritus—Doxorubicin—uterine cancer	4.75e-05	0.000276	CcSEcCtD
Anastrozole—Vomiting—Epirubicin—uterine cancer	4.61e-05	0.000268	CcSEcCtD
Anastrozole—Diarrhoea—Doxorubicin—uterine cancer	4.6e-05	0.000267	CcSEcCtD
Anastrozole—Rash—Epirubicin—uterine cancer	4.58e-05	0.000266	CcSEcCtD
Anastrozole—Dermatitis—Epirubicin—uterine cancer	4.57e-05	0.000265	CcSEcCtD
Anastrozole—Headache—Epirubicin—uterine cancer	4.55e-05	0.000264	CcSEcCtD
Anastrozole—Dizziness—Doxorubicin—uterine cancer	4.44e-05	0.000258	CcSEcCtD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	4.37e-05	0.00456	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—ESR1—uterine cancer	4.34e-05	0.00453	CbGpPWpGaD
Anastrozole—Nausea—Epirubicin—uterine cancer	4.31e-05	0.00025	CcSEcCtD
Anastrozole—Vomiting—Doxorubicin—uterine cancer	4.27e-05	0.000248	CcSEcCtD
Anastrozole—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	4.26e-05	0.00445	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	4.25e-05	0.00443	CbGpPWpGaD
Anastrozole—Rash—Doxorubicin—uterine cancer	4.23e-05	0.000246	CcSEcCtD
Anastrozole—Dermatitis—Doxorubicin—uterine cancer	4.23e-05	0.000246	CcSEcCtD
Anastrozole—Headache—Doxorubicin—uterine cancer	4.21e-05	0.000244	CcSEcCtD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.17e-05	0.00435	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	4.12e-05	0.0043	CbGpPWpGaD
Anastrozole—Nausea—Doxorubicin—uterine cancer	3.99e-05	0.000232	CcSEcCtD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	3.97e-05	0.00414	CbGpPWpGaD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	3.92e-05	0.00409	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	3.83e-05	0.004	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	3.78e-05	0.00394	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.75e-05	0.00391	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	3.74e-05	0.0039	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	3.64e-05	0.0038	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	3.52e-05	0.00368	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	3.47e-05	0.00363	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	3.28e-05	0.00342	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	3.22e-05	0.00336	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	3.2e-05	0.00334	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—SRD5A2—uterine cancer	3.15e-05	0.00328	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—NDUFB11—uterine cancer	3.15e-05	0.00328	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.13e-05	0.00326	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.06e-05	0.00319	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	3.01e-05	0.00314	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	2.97e-05	0.0031	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	2.89e-05	0.00301	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	2.89e-05	0.00301	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.89e-05	0.00301	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	2.81e-05	0.00293	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	2.8e-05	0.00293	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.79e-05	0.00291	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.72e-05	0.00284	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	2.67e-05	0.00279	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	2.59e-05	0.0027	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—EP300—uterine cancer	2.59e-05	0.0027	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	2.56e-05	0.00267	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	2.54e-05	0.00265	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	2.54e-05	0.00265	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.47e-05	0.00258	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	2.45e-05	0.00256	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	2.4e-05	0.00251	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	2.37e-05	0.00248	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.32e-05	0.00242	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.29e-05	0.00239	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—STAR—uterine cancer	2.28e-05	0.00237	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—AKR1B1—uterine cancer	2.28e-05	0.00237	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.26e-05	0.00236	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.26e-05	0.00236	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.21e-05	0.00231	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.18e-05	0.00228	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.16e-05	0.00226	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	2.09e-05	0.00218	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.04e-05	0.00213	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.93e-05	0.00202	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.93e-05	0.00202	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.85e-05	0.00194	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—POLD1—uterine cancer	1.79e-05	0.00186	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	1.74e-05	0.00181	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.71e-05	0.00178	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.69e-05	0.00176	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—AKR1C1—uterine cancer	1.67e-05	0.00174	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.66e-05	0.00173	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.57e-05	0.00163	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—RRM2—uterine cancer	1.49e-05	0.00155	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—DCN—uterine cancer	1.45e-05	0.00151	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.42e-05	0.00148	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.39e-05	0.00145	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.39e-05	0.00145	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP11A1—uterine cancer	1.36e-05	0.00142	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.35e-05	0.00141	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—AKR1C3—uterine cancer	1.29e-05	0.00134	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.28e-05	0.00133	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.19e-05	0.00124	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.19e-05	0.00124	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.16e-05	0.00121	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.09e-05	0.00114	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.01e-05	0.00105	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—STAR—uterine cancer	1.01e-05	0.00105	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—STK11—uterine cancer	1e-05	0.00105	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	9.95e-06	0.00104	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.4e-06	0.000981	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SRD5A2—uterine cancer	9.18e-06	0.000958	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NDUFB11—uterine cancer	9.18e-06	0.000958	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.97e-06	0.000936	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—AKR1B1—uterine cancer	8.6e-06	0.000898	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—STAR—uterine cancer	8.6e-06	0.000898	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.5e-06	0.000887	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—POLD1—uterine cancer	7.9e-06	0.000824	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—MTHFR—uterine cancer	7.53e-06	0.000785	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—AKR1C1—uterine cancer	7.39e-06	0.000771	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—POLD1—uterine cancer	6.75e-06	0.000705	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—STAR—uterine cancer	6.64e-06	0.000693	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—AKR1B1—uterine cancer	6.64e-06	0.000693	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.63e-06	0.000692	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—RRM2—uterine cancer	6.59e-06	0.000687	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—DCN—uterine cancer	6.39e-06	0.000667	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—AKR1C1—uterine cancer	6.32e-06	0.000659	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP11A1—uterine cancer	6.02e-06	0.000629	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—AKR1C3—uterine cancer	5.69e-06	0.000594	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—RRM2—uterine cancer	5.63e-06	0.000587	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—DCN—uterine cancer	5.46e-06	0.00057	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—POLD1—uterine cancer	5.21e-06	0.000544	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP11A1—uterine cancer	5.15e-06	0.000537	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.87e-06	0.000509	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—AKR1C3—uterine cancer	4.86e-06	0.000507	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—STK11—uterine cancer	4.43e-06	0.000463	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP19A1—uterine cancer	4.43e-06	0.000463	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—RRM2—uterine cancer	4.34e-06	0.000453	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—DCN—uterine cancer	4.22e-06	0.00044	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTEN—uterine cancer	4.19e-06	0.000437	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.16e-06	0.000434	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—EP300—uterine cancer	3.99e-06	0.000417	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP11A1—uterine cancer	3.97e-06	0.000415	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.97e-06	0.000414	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—STK11—uterine cancer	3.79e-06	0.000395	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP19A1—uterine cancer	3.79e-06	0.000395	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.75e-06	0.000392	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.56e-06	0.000371	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.39e-06	0.000354	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—MTHFR—uterine cancer	3.33e-06	0.000348	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CA—uterine cancer	2.95e-06	0.000308	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.94e-06	0.000306	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.92e-06	0.000305	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—STK11—uterine cancer	2.92e-06	0.000305	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—MTHFR—uterine cancer	2.85e-06	0.000297	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.51e-06	0.000262	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—AKT1—uterine cancer	2.41e-06	0.000252	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—MTHFR—uterine cancer	2.2e-06	0.000229	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTEN—uterine cancer	1.85e-06	0.000193	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—EP300—uterine cancer	1.77e-06	0.000184	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTEN—uterine cancer	1.58e-06	0.000165	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—EP300—uterine cancer	1.51e-06	0.000158	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.31e-06	0.000136	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTEN—uterine cancer	1.22e-06	0.000128	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—EP300—uterine cancer	1.17e-06	0.000122	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.12e-06	0.000117	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—AKT1—uterine cancer	1.07e-06	0.000111	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—AKT1—uterine cancer	9.13e-07	9.52e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CA—uterine cancer	8.62e-07	9e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—AKT1—uterine cancer	7.04e-07	7.35e-05	CbGpPWpGaD
